2018 Advancements in Biomarker Assays and Stem Cell Therapies - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 28, 2018--The “Advancements in Biomarker Assays and Stem Cell Therapies” report has been added to ResearchAndMarkets.com’s offering.
This report presents trends across biomarker assays and stem cell therapies: a blood test for traumatic brain injury, use of umbilical cord mesenchymal stem cells and adipose-derived mesenchymal stem cells for treatment of liver cirrhosis, and using mesenchymal stem cells for treatment of ulcerative colitis are profiled. The corresponding clinical trials scenario is also depicted.
Key Topics CoveredNovel Blood Test for Traumatic Brain Injury Umbilical Cord Mesenchymal Stem Cells for Liver Cirrhosis Adipose-derived Mesenchymal Stem Cells for Liver Cirrhosis Mesenchymal Stem Cell Therapy to Treat Ulcerative Colitis Clinical Trial Analysis of Studies Conducted by Banyan Biomarkers Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/zmnv52/2018_advancements?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180928005667/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Stem Cells ,Biomarkers
INDUSTRY KEYWORD: STEM CELLS HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/28/2018 06:17 PM/DISC: 09/28/2018 06:17 PM